|
FY2020
12 months to Dec 31, 2021
|
FY2019
5 months to Dec 31, 2020
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income / (loss) | ||
| Adjustments to reconcile net income / (loss) to net cash used in operating activities: | ||
| Interest earned on cash and marketable securities held in Trust Account | ||
| Change in fair value of derivative warrant liabilities | ||
| Offering costs associated with warrants recorded as liabilities | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Accrued expenses | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Investment of cash and marketable securities in Trust Account | ||
| Transfer from Trust Account | ||
| Net cash provided by/(used in) investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from issuance of Class B common stock to Sponsor | ||
| Proceeds from sale of Units, net of underwriting discounts paid | ||
| Proceeds from sale of Private Placement Warrants | ||
| Proceeds from promissory note - related party | ||
| Repayment of promissory note - related party | ||
| Payment of offering costs | ||
| Net cash provided by financing activities | ||
| Net Change in Cash | ||
| Cash - Beginning of period | ||
| Cash - End of period | ||
| Non-cash investing and financing activities: | ||
| Initial classification of common stock subject to possible redemption | ||
| Change in value of common stock subject to possible redemption | ||
| Deferred underwriting fee payable | ||
| Initial classification of derivative warrant liabilities |
Loading...
